Current Ratio in % of Insight Molecular Diagnostics Inc. from Q3 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Insight Molecular Diagnostics Inc. quarterly Current Ratio history and change rate from Q3 2016 to Q3 2025.
  • Insight Molecular Diagnostics Inc. Current Ratio for the quarter ending 30 Sep 2025 was 308 %, a 206% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Insight Molecular Diagnostics Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 308 +207 +206% 30 Sep 2025
Q2 2025 244 +100 +69.8% 30 Jun 2025
Q1 2025 189 +12.3 +6.94% 31 Mar 2025
Q4 2024 104 -95.1 -47.9% 31 Dec 2024
Q3 2024 101 -112 -52.6% 30 Sep 2024
Q2 2024 143 -90.9 -38.8% 30 Jun 2024
Q1 2024 177 -84.9 -32.5% 31 Mar 2024
Q4 2023 199 -57.3 -22.4% 31 Dec 2023
Q3 2023 212 -59 -21.7% 30 Sep 2023
Q2 2023 234 -54.7 -18.9% 30 Jun 2023
Q1 2023 261 -2.05 -0.78% 31 Mar 2023
Q4 2022 256 -94.3 -26.9% 31 Dec 2022
Q3 2022 271 -55.9 -17.1% 30 Sep 2022
Q2 2022 289 +6.03 +2.13% 30 Jun 2022
Q1 2022 264 -34.2 -11.5% 31 Mar 2022
Q4 2021 350 +168 +92% 31 Dec 2021
Q3 2021 327 +63.4 +24% 30 Sep 2021
Q2 2021 283 -92.5 -24.6% 30 Jun 2021
Q1 2021 298 -235 -44.1% 31 Mar 2021
Q4 2020 183 -640 -77.8% 31 Dec 2020
Q3 2020 264 -411 -60.9% 30 Sep 2020
Q2 2020 376 -190 -33.6% 30 Jun 2020
Q1 2020 533 +125 +30.5% 31 Mar 2020
Q4 2019 823 +594 +260% 31 Dec 2019
Q3 2019 674 +433 +180% 30 Sep 2019
Q2 2019 565 +321 +132% 30 Jun 2019
Q1 2019 408 +173 +73.3% 31 Mar 2019
Q4 2018 228 -15.6 -6.4% 31 Dec 2018
Q3 2018 241 -28.3 -10.5% 30 Sep 2018
Q2 2018 244 -51.8 -17.5% 30 Jun 2018
Q1 2018 236 -68.7 -22.6% 31 Mar 2018
Q4 2017 244 -59.5 -19.6% 31 Dec 2017
Q3 2017 269 -69.8 -20.6% 30 Sep 2017
Q2 2017 296 30 Jun 2017
Q1 2017 304 31 Mar 2017
Q4 2016 304 31 Dec 2016
Q3 2016 339 30 Sep 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.